Related Experiment Video
Updated: Apr 3, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Ebola and blood transfusion: existing challenges and emerging opportunities
1Laboratory Medicine Department, Faculty of Applied medical Sciences, Jazan University, Kingdom of Saudi Arabia. karunamoorthi@gmail.com.
Objective:
The deadly Ebola virus has been first known to mankind since 1976. In the past decades, Ebola outbreaks has often been ignored/neglected as erupted in the rural remote/isolated areas of Africa. The recent 2013-2014 epidemic is the most wide-spread with high incidence rates, morbidity and, mortality in the Ebola history. Eventually, the World Health Organization (WHO) has declared it as a 'Public Health Concern of the International Community'. This scrutiny was conducted to initiate a serious debate on various aspects of Ebola, particularly blood transfusion as an empirical therapeutic modality.
Methods:
A search has been performed using the premier scientific databases, WHO documents, and English language search engines. Of 278 potential articles that were identified using a fixed set of criteria, a convenience sample of eighty-two appropriate articles was chosen for this review.
Results:
The current EBO outbreak is predominantly driven by various confounding risk-factors like: (1) frail health care system, (2) unique cultural and religious customs, (3) huge-shortage of skilled professionals, (4) no licensed therapeutic agents, (5) ill-prepared monitoring and early warning systems, and (6) strained budgets; all these have bolstered this epidemic. As lack of neither specific treatments nor reliable interventions to quickly quell this epidemic, WHO has indorsed 'blood transfusion as an empirical therapeutic modality'. Currently, several clinical trials are underway, particularly the two Ebola candidate vaccines and several antiviral drugs and it has been observed that the initial results are quite promising. However, there are several daunting ethical and practical challenges ahead to stem off this outbreak.
Conclusions:
The Ebola-hit poverty stricken West-African countries struggle to contain the outbreak, due to lack of potent therapeutics. Consequently, blood-transfusion could serve as an ideal therapeutic modality to save millions of lives. Therefore, industrialized nations and international agencies must aid them to combat with this catastrophe. Besides, it must warrant further multi-layered interventions and interagency policies, in order to build an Ebola-free safe world in the near future.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Cross-reactivity
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Rh Blood Group
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...